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NODES and Reid (1963) showed that the levels of certain acid-soluble nucleo-
tides are abnormal in precancerous liver and in primary hepatomas induced by
3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB). The present paper on
enzymes concerned in the metabolism of uridine nucleotides amplifies brief
reports by Reid (1962a, b). The reactions now examined are shown diagramati-
cally in Fig. 1 of the paper by Nodes and Reid (1963) and again, together with
the results obtained, in the Discussion which concludes the present paper and
which seeks to correlate the variouis findings.
EXPERIMENTAL
A full description of the general techniques for preparing and handling the
tissues, and of the historical appraisal of the tissues, has been given by Nodes and
Reid (1963). Homogenates were usually prepared in 0-25 M sucrose medium and,
when supernatant fractions were required, centrifuged for 90 minutes at 20,000 g.
or, in a few experiments where a higher force was possibly advantageous, for
60 minutes at 105,000 g.
Abbreviations are usually restricted to standard ones as used, for example, in
the Biochemical Journal; certain other abbreviations as used in tlhe section
"Assay of enzymic activities " are defined in that section.
Labelled Compounds
The Radiochemical Centre, Amersham, supplied L-['4C]aspartic acid (27.5
,ac/mg., generally labelled), [6-14C]orotic acid (monohydrate, 55 ,uc/mg.;
[4-_4C]orotic acid by Chemical Abstracts nomenclature), and [2-14C]uracil (i.e.
uracil labelled in the carbon between the two N atoms). For the purpose of in
vitro assays, these labelled compounds were diluted with the unlabelled compounds
as supplied by British Drug Houses, Poole, Dorset.
No commercial source being available at the outset, [14C]carbamylaspartic
acid (ureidosuccinic acid) was prepared by the method ofNyc and Mitchell (1947)
from unlabelled KCNO and generally labelled L-aspartic acid diluted 30-fold with
unlabelled DL-aspartic acid; the product contained 0-105 ,ac/,umole of L-isomer.
With unlabelled L-instead of DL-aspartic acid for dilution, acidification of the
reaction mixture did not readily give the expected precipitate. Late in the
investigation DL-[14C]carbamylaspartic acid (labelled in the ureido group; 12-5
,uc/mg.) became available from Nichem Inc. of Bethesda, Md., U.S.A.; it was
diluted 5-fold with unlabelled DL-carbamylaspartic acid (Sigma Chemical Co.,St. Louis, Miss., U.S.A.). Carbamylaspartic acid was found to be highlv unstable
if stored in solution, even at -20° and at neutral pH.
To obtain labelled uridine, labelled UMP synthesized enzymically from
[6-14C]orotic acid was dephosphorylated by incubation with snake venom (Russell
Viper), and the reaction products were separated by chromatography of the
deproteinized incubation mixture on Dowex 1 resin. In later assays ofuridine
kinase use was made of [L4C]uridine supplied by Schwartz BioResearch, Orange-
burg, N.Y., U.S.A.; its labelling was " general " (2.1 ,uc/mg.) but not uniform,
being mainly in the ribose as also found by Gaito and Prusoff (1962). It was
diluted with unlabelled uridine before use.
UDPglucose labelled in the glucose moiety was prepared by incubating UTP
with [14C]glucose-l-phosphate, in the presence of UDPglucose pyrophosplhorylase
in the form of crude " Zwischenferment " prepared from dried brewer's yeast
(LePage and Mueller, 1949). The [14C]glucose-l-phosphate was prepared by
exhaustive digestion of generally labelled starch (0.4 ,tc/mole; kindly provided
by Dr. R. J. Bayly of the Radiochemical Centre) with phosphorylase (Sigma)
in phosphate buffer. A solution of UTP (0.3 m-mole), labelled glucose-l-phos-
phate (0.1 m-mole), ATP (0-2 m-mole) and Zwischenferment (equivalent to 8 g.
dried yeast), in 20 ml. 0-015 M K phosphate buffer (pH 7.2) containing MgC12
(0.005 M), was incubated at 30° for 30 minutes, by which time the reactioin had
apparently reached equilibrium. After deproteinization with HC104, and
removal ofC104- ions as KC104, the products were chromatographically separated
on Dowex 1 resin (20 cm. column). Glucose-l-phosphate (together with any
glucose 6-phosphate) was eluted in advance of UMP. UDPglucose was eluted
as a sharp peak, with uniform specific radioactivity through the peak; there was
negligible breakdown to glucose-l-phosphate during the final sublimation of the
ammonium formate from the freeze-dried effluent.
These procedures gave [14C]UDPglucose in a yield (based on glucose-i-
phosphate) of the order of 10 per cent. It appeared that the pyrophosphorylase
preparation deteriorated ifstored evenfor a few days (as a suspension in (NH4)2SO4
solution at 30), and that the yield of UDPglucose could be improved if, with
a view to removing the pyrophosphate formed in the reaction, inorganic pvro-
phosphatase (equivalent to 1 g. dried yeast) were added to the incubation medium.
The pyrophosphatase was obtained from dried brewer's yeast (Heppel, 1955);
the precipitate obtained by (NH4)2504 was used without further purification,
since it attacked ATP or UTP only slowly in comparison with inorganic pyro-
phosphate. Alternative methods for the preparation of [14C]UDPglucose have
been reported, but with few details (Leloir, Olavarria, Goldemberg and Carminatti,
1959; Robbins, Traut and Lipmann, 1959).
Assay of enzymic activities
In each assay, the tissue preparation, buffer (the pH value stated being for
room temperature), activators, substrate concentration, incubation time and other
variables were chosen with a view to obtaining activity which was optimal in rate
and was linear with respect to tissue concentration and time. Usually the literature
gave some guidance, although it was sometimes found advisable to use shorter
incubation times than those published; the activities now found in normal rats
were of the same order as published values. The following layout, given together
180 E. REII)ENZYMES IN URIDINE NUCLEOTIDE METABOLISM
with notes on some general techniques, is used for each enzyme or enzyme system:
(1) Reaction number (cf. Fig. 1 in Nodes and Reid, 1963), and International
Union of Biochemistry Code Number if one exists. (2) References of particular
relevance to the method adopted. (3) Tissue addition: nature of preparation
(hom.= homogenate including nuclei, cyt.= cytoplasm, mit.= mitochondrial
fraction, mic.= microsomal fraction, sup.- supernatant fraction), approximate
amount as equivalent offresh liver, and volume inwhich added. (4) Otheradditions.
(5) Incubation: temperature if not 370 (the tubes being constantly shaken if risk
of particles settling), time, and final treatment; HC104 (or " TCA ") denotes
the treatment of the chilled incubation mixture with perchloric acid (or trichloro-
acetic acid), added to give a final concentration of 5 per cent w/v, followed by
removal ofthe proteinprecipitate on a bench centrifuge. (6) Final analysis, on the
protein-free supernatant or an aliquot thereof: usually by measuring ultraviolet
extinction (E), orby determining inorganic orthophosphate (add 1 vol. of 5 per cent
HC104-0 6 per cent ammonium molybdate, followed by reduction with ascorbic
acid and measurement of E720), or by chromatography with formic acid (FA)-
ammonium formate (AmF) systems on 6-5 x 1 cm. columns of Dowex-I resin
either manually with no solvent gradient oron afraction collector (5 ml. collections)
with a discontinuous solvent gradient (cf. Hurlbert, Schmitz, Brumm and Potter,
1954) and with 125 ml. of water in the mixing flask initially. Where " plate and
count " is specified, the amount of reaction product is determined by plating the
material-usually a portion ofcolumn effluent-at infinite thinness and measuring
the radioactivity in an end-window counter (Reid, 1964). Before chromatography
on Dowex-1, HC104 supernatants were sometimes (where indicated below) heated
at 1000 for 20 minutes to decompose, to UMP, uridine nucleotides other thanUMP.
All HC104 supernatants to be chromatographed were neutralized (made alkaline
to phenol red) with KOH solution and freed from the KC104 which precipitated
on standing at 00. (7) Remarks, especially onpossibleimprovements in themethod;
where mention is made of a " pulp ", this was liver tissue expressed through a
squeezer before homogenizing (cf. De Lamirande, Daoust and Cantero, 1961).
Aspartic transcarbamylase.-(1) Step ] ; 2.1.3.2. (2) Reichard (1954);
Calva, Lowenstein and Cohen (1959); Smith and Baker (1959). (3) Hom. or
cyt. (can be stored several months at -20°), = c. 70 mg., in 0-35 ml. To deter-
mine the non-enzymic condensation ofthe carbamylphosphate and aspartate (c. 10
per cent of the enzymic condensation), run a blank with the tissue addition just
before the final HC104 addition. (4) 5 ,umoles freshly dissolved carbamylphos-
phate (Sigma, crude lithium salt; 1-53 mg.) in 0-15 ml. 0 33 M pH 8*0 tris; 3
ctmoles [14C]aspartate (0-25,tc) in 0 05 ml. water. (5) 20 min. (not linear if
longer) ; finally add c. 1 /imole unlabelled carbamylaspartate as " carrier ", then
HC104. (6) Dowex-1, manual, avoiding prolonged delay before loading (neutral
solution can be kept one night at -20°): apply 42 ml. of 0 05 M AmF adjusted
to pH 3-2 with FA, to elute the aspartate (last 7 ml. of effluent should have
negligible radioactivity), then 12 ml. 6 N FA to elute the carbamylaspartate.
Plate and count. (7) Chromatography on Dowex-50 resin would be simpler
(Bresnick, 1962).
Dihydro-orotase (carbamylaspartate dehydrase) and dihydro-orotate dehydro-
genase.-(1) Step 2; 3.5.2.3 and 1.3.3.1. (2) Wu and Wilson (1956); Smith
and Baker (1959); cf. Bresnick and Hitchings (1961) and Stevens and Stocken
(1963). (3) For "free " activity, fresh hom. or cyt., - c. 100 mg., in 0 5 ml.
1810)25 M sucrose. For " total " activity, hom. or cyt. (can be stored at 20°, even
2 years), c. 60 mg., diluted to 0-5 ml. with water and either frozen and thawed
altogether 8 times (activity tended to be lower if 5 or 12 times, and with only one
freeze-thaw in isotonic medium was only 30 per cent above the " free " activity).
or pre-incubated for 10 minutes in presence of Triton-X-100 (0.25 per cent).
No blank is necessary. (4) 0-8 ,tmoles freshly dissolved ['4C]carbamylaspartate
( 0-1 ,iC of L-isomer radioactivity) in 0-15 ml. 0*33 M pH 8X0 tris. (With 0*8
limoles the enzyme system was almost saturated. With pH 5-7 acetate buffer
the activity was only 20 per cent of that with pH 8 0 tris.). (5) 50 min. (free
activity) or 80 minuites (total activity)-not linear if longer. Finally add c. 1
,umole unlabelled orotate as a " carrier " and " marker ", then HClO4. (6)
IDowex-l, manual: apply 40 ml. 1 N FA to remove the carbamylaspartate, 5 ml.
4 N FA, and successive 6 ml. portions of 4 N FA-0-4 M AmF. Orotate (as detected
by E260 and E275 readings) usually comes off with the 3rd or 3rd and 4th 6 ml.
portions, and the preceding portions should have negligible radioactivity. Plate
and count.
Orotidylate pyrophosphorylase and orotidylate decarboxylase.-(1) Step 3:
2.4. 2. 10 and 4. 1. 1 . 23. (2) Hurlbert and Reichard (1955); Herbert, Potter and
Hecht (1957). (3) Either fresh supernatant from centrifugation of mit., i.e.
mic. + sup., or - if only total uridine nucleotide formation being measured,
the final HClO4 supernatant then being heated at 100°- sup. only (can
have been kept several months at 20°), = c. 200 mg., in 1 ml. (4) 20
,umoles KH2PO4, 6-7 ,umoles MgC12, 1.1 ,umoles ATP (Sigma, K salt), 1-1 ,umoles
ribose-5-phosphate and 2-2 ,umoles hexose diphosphate (each as the K salt,
prepared from the Ba salt), 90 ,umoles nicotinamide, and 0-22 ,umoles [6-14C]orotate
(0.4 ,uc; with 0-22 ,umole the enzyme system was almost saturated - all dissolved
in 1-1 ml., with addition of KOH to give pH 7-2. 0-2 ,umoles NAD, in 0-1 ml.
(The addition in some experiments of 2 ,umoles glucose-i-phosphate did not
markedly increase the amount ofUDPglucose formed.) (5) 300, 12 minutes (may
not be linear if longer); finally add c. 0-3 ,amole each of unlabelled UMP, UDP,
UTP and UDPglucose as " carriers " and " markers ", then HClO4. If only
total uridine nucleotide formation is to be measured, heat the HC104 supernatant
at 1000. (6) Dowex-1, gradient: 30 tubes with 6 N FA, UMP (detected by E260
measurements) being usually in tubes 19-23 followed by orotate (verify that no
orotate radioactivity overlaps the UMP). Then, if individual uridine nucleotides
are to be measured, collect a further 30 tubes with 4 N FA-1-5 M AmF: the
UDPglucose peak is typically in tube 37 (verify that no orotate radioactivity
immediately precedes it), the UDP peak in tube 42, and the UTP peak in tube 50.
Plate and count the effluents containing uridine nucleotides, and also-if a
measure of uridine or uracil formed by catabolism of the nucleotide products is
desired-the original washings and initial effluent (tubes 1 and 2), containing
material not adsorbed on the column. (7) Of the total radioactivity recovered
in uracil compounds, on the average about one-fifth was in each of the products
(UMP, UDP, UTP, UDPglucose and uridine/uracil); but the relative amounts
varied from one experiment to another. Liver " pulp " was only 32 per cent as
active as whole liver (mean of 4 experiments), and the residue from the squeezer
showed little activity.
Uridine kinase-(1) Step 5; 2. 7. 1.21 if identical with bacterial thymidine
kinase. (2) Reichard and Skold (1958). (3) Sup. (can have been kept several
182 E. REIDENZYMES IN URIDINE NUCLEOTIDE METABOLISM1
months at 200), = c.80 mg., in 0 4 ml. (4) 5 ,tmoles MgCl2, 3-2 ,amoles ATP
(K salt), 6-7 pimoles phosphoglycerate (K salt, prepared from Ba salt), and 0-5
pymole [14C]uridine ( 0 05 ,tc; position of label immaterial), in 0-15 ml. 0-1 M
pH 7-4 tris. (5) 20 minutes (may not be linear iflonger); finally add c. 0-2 ,umole
each of unlabelled UMP, UDP, UTP and UDPglucose, then HC104; heat super-
natant at 100°. (6) Dowex-1, manual: 25 ml. 4 N FA to elute uridine, then 4
portions (10, 12, 12 and 10 ml.) of 6 N FA to elute UMP as shown by E260 measure-
ments-usually in the 3rd and 4th portions; there should be no radioactivity
in the preceding effluent. Freeze-dry the UMP-containing effluent, dissolve resi-
due in 2 ml. water, plate and count.
UTP-depho8phorylatiny enzymne(s).-(1) Step 11. (2) No literature for liver.
(3) For " free " activity, fresh hom. or cyt., c.2 mg., in 0 4 ml. 0-25 M sucrose.
For " total " activity, hom, or cyt. (can be stored several months at 20°), 2
mg. diluted to 0 4 ml. with water and frozen and thawed once; duplicates are
desirable. (4) 1-2 ,umoles UTP (K salt; enough to almost saturate the enzyme(s))
and 5 ,umoles MgCl2 (activity no lower if 0 5 /amole, but 25 per cent lower if 50
/imoles), in 0-1 ml. 0-3 M pH 7-4 tris. Run blanks without UTP, and with UTP
but no tissue. (5) 30°, 12 minutes (" free " activity may not be linear if longer),
finally HCl04. (6) Determine inorganic orthophosphate. (7) Dowex-I chroma-
tography of reaction products from an assay of total activity with a prolonged
incubation time (20 minutes) showed both UMP and UDP, the latter
predominating.
5'-UMP-depho8phorylating enzymes.-(1) Step 6; one enzyme possibly
3. 1 .3.5 (requires Mg2+ ions), and a second enzyme (probably identical with acid
phosphatase) which is less active and does not require Mg2+ ions. (2) De Lami-
rande, Allard and Cantero (1958); A.B.A. El-Aaser and E. Reid, unpublished
experiments. (3)Hom. orcyt. (trend ofresults thesame, whichever used, although
there is some activity in nuclei), c.20 mg., treated as for assay of UTP de-
phosphorylation; duplicates are desirable. (4)-(6) as for above assay of UTP
dephosphorylation, with UMP in place of UTP.
Uridine pho8phorylase.-(1) Step 4; 2.4.2.3. (2) Reiclhard and Skold
(1958). (3) Sup. (can have been frozen once only, and kept at -20° for several
weeks), = c. 8 mg., in 0 4 ml. (Sup. is as active as cyt., and need not be dialyzed
-cf. Reichard and Sk6ld, 1958). (4) 0-15 ml. 0-2 M pH 7*4 K phosphate buffer;
5 ,tmoles uridine in 0-15 ml. water (activity no higher if 30 ,tmoles), added after
incubation in case of blanks. (5) 60 minutes, the HC104 (2-3 ml.). (6) To 2 ml.
aliquot add 2 ml. N NaOH, and determine E285. To convert the E285 difference
(experimental minus blank; 1 cm. light path) to ,umoles uracil formed in the
incubation, the factor 1-2 is used. (7) It is advisable to run both experimentals
and blanks in triplicate. For linearity the E285 difference should not exceed 0-2.
Dihydrouracil dehydrogenase (uracil reductase).-(1) Step 10; 1.3. 1.2. (2)
Fritzon (1960). The dihydrouracil formed in the assay is rapidly degraded to
/J-alanine, and the latter is measured. (3) Fresh sup. (freezing may destroy the
activity), c. 8 mg., in 0 03 ml. (the 0'25 sucrose medium may contain 0-01 M
pH 8.0 tris and 0.001 EDTA); duplicates are desirable, but blanks are un-
necessary provided that the rats had not received any isotope injection. (4)
To sup. and exactly 0-025 ml. 0-15 M pH 7.4 phosphate buffer containing 0 07
,umole [6-14C]uridine (= 0 003 ,icb; " 6 " refers to the carbon atom designated
" 4 " in Chemical Abstracts). Incubate for 15 minutes to allow uridine phosphory-
183lase to convert uridine to uracil (not necessary if labelled uracil used in place of
uridine). Then add 0 5 /tmole glucose-6-phosphate (di-K or -Na), 0 3 pimoles
ATP, 7 ,tmoles nicotinamide and 3 ,umoles NaF in 0-01 ml. water to which
MgCl2 (to 0-2 mI) had been added just previously, and then 01 gtmole NADP
and 0-02 /tmole NADPH2 in 0-01 ml. water. (5) 370, 12 minutes or, for hepato-
mas, 8 minutes. Finally immerse tubes in boiling water-bath for 2 minutes,
and centrifuge. (6) Apply supernatant (amount need not be measured) to What-
man No.
1 chromatographic paper, and run with n-butanol-water (8.6: 1P4 by
vol.) until solvent front about 35 cm. from origin. Dry, and cut out (a) strip
from position of original spot up to 4 cm., containing ,-alanine, and (b) strip in
position corresponding to uridine and uracil markers (RF values c. 0 25 and 0 4
respectively). FElute, plate, calculate the ratio of counts/minute in (a) to counts/
minute in (a) + (b). (7) With normal or precancerous liver there is linearitv up
to 20 minutes of incubation, but with hepatomas there is a plateau at about 8
minutes and subsequent falling-off in apparent activity, of unknown cause
(not decarboxylation of the ,8-alanine) ; accordingly, for some of the hepatomas
the activity may have been under-estimated. The possibility that the labelled
product measured was largely 5'-UMP, rather than/,-alanine, was eliminated by
re-running pooled samples on Dowex-1 resin and measuring the radioactivity in
the effluent containing 5'-UMP. An alternative assay procedure as used for
a few of the assays, depending on measurement of the loss of radioactivity from
[2-14C]uracil (Canellakis, 1956; Potter, Pitot, Ono and Morris, 1960), gave rather
erratic results. The activity now found in normal liver was about 3 times higher
than reported by other authors.
2'(3')-UMP-dePhosphorylatinq enzymne(s).-(1) Step 9. (2) A.B.A.El-Aaser
and E. Reid, unpublished experiments. (3) Hom. or cyt. (can be stored 2 years
at-20'), = 80 mg., in 0 4 ml. water; duplicates are desirable. (4)-(6) as for
above assay of UTP dephosphorylation, but with uridylic acid (mixed 2'- and
3'- isomers) in place of UTP and with incubation at 37°, 120 minutes.
UDPglucose pyrophosphorylase.-(1) Step 12; 2. 7. 7.9. (2)-(6) see Reid
(1959).
UDPglucose dehydrogenase.-(1) Step 13; 1. 1. 1 .22. (2) Strominger, Maxwell,
Axelrod and Kalekar (1957). (3) Sup. (can have been kept several months at
20°), c. 30 mg., in 0-2 ml. ; duplicates are desirable. (4) 3 ,tmoles NAD in
2 7 ml. 0 11
M pH 8-7 glycine; 0-6 ,umole UDPglucose in 041 ml. water, or (blank)
0()1 ml. water alone. (5) and (6) Using a cuvette with1 cm. lighit path, follow the
rise in E340 at room temperature (c. 21°) an increase of unity corresponds to
0)24 ,umole of UDPglucose oxidized in the total volume, the linear portion being
taken for the calculation.
UJ)Pglucuronate glucuronyltransferase.-(1) Step 14; 2.4.1.17. (2)Dutton
and Storey (1954); Dutton (1959); G. J. Dutton, personal communication.
(3) Fresh hom., c. 300 mg., in 1-4 ml.; duplicates are desirable. (4) 0-3M
pH 7.4 tris containing 0-1IM MgCl2, 0-2 ml.; 0 17 /amoles o-aminophenol (purified
by sublimation) in 0-2 ml. 0 2 per cent ascorbic acid solution, this solution being
stable indefinitely at 20° for blanks, add the o-aminophenol solution after
the incubation; 0-4 ,tmoles UDPglucuronate (prepared from liver, or purchased;
this amount was ample for saturation), in 0-2 ml. water. (5) 230, 9 minutes (see
(7) below). Finally add 2 ml. of freshly prepared mixture (1: 1 by vol.) of 2 M
phosphoric acid and 1 25 M TCA, each previously adjusted to pH 2-1 with NaOH.
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(6) To 2*4 ml. of supernatant, add 06 ml. 0 05 per cent NaNO2, leave 1 min.,
add 0-6 ml. 0 4 per cent ammonium sulphamate, leave 2 min., and add 0-6 ml.
0 1 per centnaphthalenediamine dihydrochloride. Keep 2 hours at room tempera-
ture in the dark, centrifuge if necessary to clarify, and determine E550. A value
of 4-5 (experimental minus blank; 1 cm. light path) would represent 1 ,cmole of
o-aminophenol glucuronide in the original incubation mixture, as shown by adding
the authentic glucuronide (kindly provided by Dr. G. J. Dutton) to this mixture;
the extinction increased linearly with concentration up to E560 = 1-4. (7) Unlike
the assays performed with homogenates by Dutton and Storey (1954), the present
assays showed linearity with respect to time, although even at 200 there was
tailing off at 14 minutes. Liver pulp from rats fed azo dye showed similar
activity to whole liver. The endogenous UDPacetylglucosamine and ATP of
the fresh homogenates may, with the short incubation time employed, have been
adequate to fully activate the enzyme (cf. Pogell and Leloir, 1961); but supple-
mentation with these nucleotides was not tried.
UDPglucose-glycogen tran8glucosyla8e.-(1) Step 15; 2.4. 1.11. (2) Leloir
et al. (1959); Robbins et al. (1959). (3) Fresh hom. (activity low if frozen)
containing 0-01 M EDTA, = c. 1 mg., in 0-06 ml.; triplicates are desirable, but
blanks are unnecessary. (4) 0-025 ml. of 5 per cent glycogen (British Drug
Houses Ltd.) in 0-15 M pH 8-3 tris-maleate buffer containing 0-012 M EDTA;
0-23 /tmoles (0.02 jtc) glucose-labelled [14C]UDPglucose in 0-015 ml. 0 033 M
glucose-6-phosphate solution (K salt, prepared from Ba salt). (5) 300, 30 minutes.
Finally add 0 9 ml. 33 per cent (w/v) KOH solution, heat at 1000 for 20 minutes,
add 1-3 ml. ethanol, centrifuge, and wash the glycogen precipitate with a mixture
of N NH3 solution and ethanol (1: 1-3 by vol.). (6) Dissolve precipitate at 370
in 1-0 ml. water, and plate. (7) Liver " pulp " was almost as active as whole
liver. Addition of glucose-l-phosphate (unlabelled) did not lower the activity,
thereby confirming that phosphorylase action on any glucose-l-phosphate derived
from the UDPglucose was not contributing to the observed activity. Assays
on sub-cellular fractions showed no activity in nuclear fractions, and a variable
distribution between cytoplasmic particles (mitochondria and microsomes) and
supernatant, in accord with evidence (Leloir and Goldemberg, 1960; Luck,
1961) that the enzyme is loosely linked to glycogen particles. In agreement with
Leloir et al. (1959, 1960), magnesium ions were without effect or even inhibitory.
The activity might have been slightly higher if glycine buffer had been used
(Leloir and Goldemberg, 1960).
RESULTS
As will be evident from the tables, there was usually no marked difference in
the results between " hyperplastic nodules " and hepatomas, or between hepato-
mas differing in histological characteristics. It is particularly noteworthy that
hepatomas with so-called " necrosis " were as high in their content of synthetic
enzymes as hepatomas with little necrosis. The changes in precancerous liver
were similar for different lobes of the liver (not shown in the tables).
Synthesis of uridine-5'-monophosphate (UMP).-In agreement with Calva,
Lowenstein and Cohen (1959), primary hepatomas had an increased level of
aspartic transcarbamylase (step 1, Table I). However, with 21-41 days' feeding
of the carcinogenic azo dyes there was a slight fall in activity. With a shorter
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feeding period (3'-Me-DAB) the level did tend to be high, as in hepatomas, but
this trend is evidently unrelated to the carcinogenicity of the dye (Table I).
TABLE I.-Enzymes Concerned in Synthesis of Uridine 5'-Monophosphate
In this and subsequent Tables, the mean experimental values are tabulated
relative to controls taken as 100, all activities having first been calculated as
,umoles/g./min. Values following the symbol ± represent standard errors.
(In parentheses: number of observations and, where appropriate, the
probability Pthat the difference from controls could be due to chance.) The
numberingofthe steps is as inFig. 1 ofthepaperbyNodes and Reid (1963).
Carbamylphos- Carbamylaspartate
phate -* car- orotate (step 2) Orotate Uridine
bamylaspartate - 5'-UMP -÷ 5'-UMP
(step 1) "Free" "Total " (step 3) (step 5)
Mean value in controls 0 5 0-0022 0 0055 0 007 0-020
umoles/g./min. (=100) (=100) (=100) (=100) (=100)
12-19 days .
35-41 days .
12-19 days .
24-41 days .
3 months, then 3:
off dye
3 days
5-20 days
21-45 days .
80 days
12-20 days .
21-35 days .
36-51 days .
Liverfrom ratsfed 2-Me-DAB (virtually non-carcinogenic)
144 (2) 79 (1) 89 (1)
81 (1) 120 (1) 72 (1)
Liverfrom rat8fed 4'-Me-DAB (virtually non-carcinogenic)
230 (2) 114 (1) 95 (1)
107 (2) 80 (2) 145 165
(3) L±23
months 224 F(P<
(1)J 0-1)
Liverfrom rat8fed 3'-Me-DAB (highly carcinogenic)
113 (2)-
170 ±51 (4) 150 ±19 140 (3)1 118 (9) 131
(7; P<0-05) 128 ±13
73 ±8 104 ±14 (4) 123 (8)J ±22 154 (7) (P< ]
(8; P<0-025) 0-05)
73 (1)
Liverfrom rat8fed 4'-F-DAB (highly carcinogenic)
111 ±15 (5) 69 (3) 141 (3) 134 ]
±8
55 (2) 70 93 <30 (4) 125 (2) (P<
.±11 J 0-025)
87 (2) F(P<
J 0.1)
120 ±10
(5; P<0* 1)
" Normal " liver adjoining nodule8 induced by 3'-Me-DAB
183 (3)
Hepatoma nodules
Nodule8 induced by 3'-Me-DAB
187 ±22 163 ±26 191 ±35 (12;
(6; P<0- 025) (11; P<0- 05) P<0- 025)
Hepatoma &ub-categorie:
Metastases . 204 (1) 142 (1)
Necrosis limited . 150 (2) 134 (5)
Necrosisveryextensive 179 (2) 180 (4)
Adenocarcinoma . 133 (2) 227 (5)
Trabecular carcinoma 192 (2) 160 (2)
Mainly small-celled
Mainly large-celled . 180 (1) 136 (3)
Leucocytes abundant 120 (1) 103 (2)
Hyperplastic nodules . 203 (2)
Hepatoma and hyperplastic nodule 8ub-category:
Extensive fibrosis . 197 (4) 160 (6)
200 (1)
152 (6)
208 (4)
200 (2)
161 (2)
141 (2)
190 (4)
182 (1)
270 (2)
33 ±8 (5;
P<0-001)
30 (4)
32 (1)
33 (3)
44 (1)
36 (4)
21 (2)
88 (4) 87
80 (1) ±8
102 ±32 (4)
90 (2)
100 (1)
170) 153
(9) ±15
138 (P<
(7) 0-005)
126 ±5 (7;
P<0-005)
65 ±13
(4; P<0- 1)
229 (3)
83 (3)
274 ±38 (6;
P<0-005)
475 (1)
244 (4)
240 (1)
280 (1)
280 (3)
140 (1)
253 (2)
140 (1)
384 (2)
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The next step in the de novo pathway for synthesis of UMP showed, both for
"free " and for " total " activity, high values in hepatomas and, less strikingly, in
precancerous liver (step 2, Table I). The further step whereby orotate is con-
verted into UMP showed impaired activity in hepatomas, but somewhat enhanced
activity in precancerous liver (step 3, Table I). A similar but possibly later
enhancement tended to occur with the non-carcinogenic dye 4'-Me-DAB. These
results for UMP formation take account of the partial transformation of the UMP
into products such as UTP ; there were no clear-cut effects of carcinogenesis oIn
the pattern of these secondary conversions (not shown in the table).
The enzyme uridine kinase, lying on the " salvage " pathway of UMP syn-
thesis, showed a striking rise in hepatomas, and a moderate rise at an early stage
of feeding with the carcinogenic azo dyes (step 5, Table I). The rise was possibly
bi-phasic in the case of 4'-F-DAB.
Catabolisrn ofuridine nucleotides.-The enzyme(s) concerned in dephosphoryla-
tion of UTP show, at least with respect to " free " activity, enhanced activity in
hepatomas and in liver from rats fed carcinogenic azo dyes for more than three
weeks (step 11, Table II).
The enzymes which effect the dephosphorylation of 5'-UMP in the presence of
Mg2+ ions showed no significant change in " total " activity other than a small
and transient fall in rats fed 3'-Me-DAB (step 6, Table II). The activity as
measured is due mainly to an enzyme located in nuclei and microsomes and in
small part to an enzyme--probably acid phosphatase-which is located in lyso-
somes, is " latent " in fresh homogenates, and does not require Mg2+ ions (A. B. A.
El-Aaser and E. Reid, unpublished experiments). In experiments not tabulated
the two enzymes were assayed individually, by using fresh homogenates so that
only " free " activity was measured and by omitting Mg2+ ions respectively.
The results sunmmarized by Reid (1962a, b) for precancerous liver were in fact
mainly preliminary assays performed without Mg2+ ions, the importance of
which was not then appreciated. The further work now performed has established
that 5'-UMP dephosphorylation, whatever the assay procedure, is not consistently
enhanced in precancerous liver or hepatomas.
With 2'-(3'-)UMP as substrate, variable but usually enhanced dephosphoryla-
tion was found in hepatomas (step 9, Table II); however, for some ofthe hepato-
mas studied in these experiments, and for most of those studied more recently
(A. B. A. El-Aaser and E. Reid, unpublished experiments), the activity was normal
or even somewhat low. The further finding that uridine phosphorylase was
abnormally high in hepatomas (step 4, Table II) is not of great interest when
viewed in the light of the apparent falling-off of the normal activity with age
(see footnote to Table II).
The enzyme diihydrouracil dehydrogenase (uracil reductase) showed somewhat
depressed activity in rats fed azo dyes-even non-carcinogenic azo dyes-and
variable but, on the average, normal activity in hepatomas (step 10, Table II).
Unexplained variability in this activity has likewise been encountered, with
Hepatoma 5123 transplants, by Ono, Blair, Potter and Morris (1963).
Metabolism of conjugated uridine nucleotides.-As is shown in Table III (step
12), the activity of UDPglucose pyrophosphorylase, whereby UTP is converted
into UDPglucose, was somewhat depressed in hepatomas, and also in liver from
rats fed 3'-Me-DAB or non-carcinogenic azo dyes but not 4'-F-DAB. UDP-
glucose dehydrogenase (step 13) was likewise moderately depressed in precancerous
187liver, apparently by the carcinogenic dyes specifically, but was usually unaltered
in hepatomas.
The transglucuronylase which converts o-aminophenol into its glucuronide
showed high values in liver from rats fed azo-dyes, carcinogenic or iion-carcino-
TABLE II.-Enzymes Concerned in Catabolism of Uridine Nucleotides
Mlean value in controls,
,umoles/g./min.
12-19 days
35-51 days
12-19 days
24-51 days
5-20 days .
21-45 days
12-19 days
35-51 days
UTP dephosphoryl- 5'-UMP 2'-(3'-)UMP
ation (step 11) dephosphor- dephosphor- Uridine
____A _ ylation ylation -*uracil
" Free" " Total " (step 6) (step 9) (step 4)
6 15 5 0-35 0.4*
(=100) (= 100) (=100) (=100) (=100)
Liver from ratsfed 2-Me-DAB (virtually non-carcinogenic)
85) 85
(2) +46
136 (3) 85 (P<
(3) 0-1)
Liverfrom ratsfed 4'-Me-DAB (virtually non-carcinogenic)
134 (2)
92 (3) 92 (3) 45 (1)
Liverfrom ratsfed 3'-Me-DAB (highly carcinogenic)
98 (2) 90 +14 78 +6 (5; 100 (3) 92)
(5) P<0-025) (8) 92
176 +26 100 (1) 101 (3) 120(2) 91 ±7
(5; P< (6),
0 05)
Liverfrom ratsfed 4'-F-DAB (highly carcinogenic)
97 (2)
92 (3) * 160 +20
(5; P<
0-05)
" Normal" liver adjoining nodules induced by 3'-Me-DAB
243 +35
(4; P<
0-05)
Hepatoma nodules 145 +9
(6; P<
0-005)
Nodules induced by 3'-Me-DAB
126 +12 128 +14 168 +30
(10; P< (16; P< (11; P<
0 1) 0- 1) 005)
Hepatoma sub-categories:
Metastases . 162 (1) 77 (1)
Necrosis limited 150 (3) 119 (4)
Necrosis veryextensive 145 (2) 143 (3)
Adenocarcinoma 174 (1) 113 (2)
Trabecular carcinoma 126 (2) 130 (6)
Mainly small-celled . 182 (1)
Mainly large-celled . 145 (2) 127 (2)
Leucocytes abundant 174 (1) 141 (2)
Hyperplastic nodules . 210 (3)
Hepatoma and hyperplastic nodule sub-category:
Extensive fibrosis . 147 (5) 120 (6)
58 (1) 440 (1)
131 (8) 138 (6)
122 (5) 160 (3)
198 (3) 132 (3)
111 (9) 204 (6)
116 (1) 138 (1)
119 (4) 130 (3)
160 (3) 155 (3)
101 (3) 138 (3)
122 (11) 190 (7)
380 +59
(7; P<
0-025)
380 (7)
350 (4)
323 (2)
402 (5)
600 (2)
205 (2)
* Excluding old rats (controls for rats with nodules), for which the mean value was 0*15-an age
difference converse to that reported by Stevens & Stocken (1963): the apparently high values found
in the nodules were in fact no higher than the values for young controls.
t Excluding 3 cholangiomas, 2 of which showed markedly increased values.
Uracil
--dihydro-
uracil
(step 10)
0-14
(=100)
30 (1)
67 (1)
38 (1)
83 (2)
56 44
(2) +11
57 (P<
(3)J 0-025)
78 71
(1) L+3
69 F(P<
(3)J 0-005
98 +16
(10)
96 (4)
83 (3)
106 (2)
141 (1)
80 (1)
185 (1)
114 (3)t
91 (4)
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genic (step 14, Table III). Hepatomas showed an average activity close to
normal.
UDPglucose is the source not only ofUDPglucuronate and thence of glucuro-
nides, but also of glycogen. The transglucosylase concerned in glycogen
formation showed low activity in hepatomas, and perhaps a slight fluctuation-
a rise followed by a fall-in precancerous liver (step 15, Table III).
DISCUSSION
The histological findings (Nodes and Reid, 1963) in conjunction with the bio-
chemical findings suggest that parenchymal cells are the site of the changes
observed in the present enzymic assays on precancerous liver. One enzyme in
TABLE III.-Enzymes Concerned in Metabolisnm of Conjugated Uridine Nucleotides
Mean value in con
jumoles/g./min.
19 days
35-41 days
19 days
24-41 days
3 days .
5-20 days
21-35 days
80 days
13-20 days
27-41 days
Ltrols,
UDPglucose
pyrophosphorylase
(step 12)
0-4 (=100)
UDPglucose
dehydro-
genase
(step 13)
0-08 (=100)
UDPglucuronate
transglucuronylase
(step 14)
0 005 (=100)
Liverfrom ratsfed 2-Me-DAB (virtually non-carcinogenic)
69 (2)A 73±4 136 (2)1145±15
* 77 (2)f(P<0-01) 149 (4)f(P<0 05)
Liverfrom ratsfed 4'-Me-DAB (virtually non-carcinogenic)
65 (2) 92 (2) 107 (2)1181
106 (1) 176 (3) 210 (5)f±61
Liverfrom ratsfed 3'-Me-DAB (highly carcinogenic)
175 (1) 127 (2) 118 17 (2)
74 (4) 115 (7) ±11 127 ±38 (8)
t77 ±9 J
79 (6)J(P<0-05) 68 ±10 212 (7) 214 ±46
(5; P<0 05) (P<0-05)
233 (1)J
Liverfrom ratsfed 4'-F-DAB (highly carcinogenic)
94 ±16 (5) 67 ±11 100 (2)
(5; P<0-05)
146 (3) 117 (3) 149 ±28 (4)
UDPglucose-
glycogen
trans-
glucosylase
(step 15)
0.9 (=100)
Hepatoma nodules .
Hepatoma sub-categories:
Metastases .
Necrosis limited .
Necrosis very extensive
Adenocarcinoma
Trabecular carcinoma .
Mainly small-celled
Mainly large-celled
Hyperplastlc nodules
" Normal " liver adjoining nodules induced by 3'-Me-DAB
125 (3) 152 426 (4) 72 (3)
Nodules induced by 3'-Me-DAB
59 ±14 (9; 91 ±21 (8) 86 ±24 (7)
P<0-025)
7 (1)
74 (6)
41 (2)
63 (3)
51 (5)
69 (4)
28 (2)
Hepatoma and hyperplastic nodule sub-category:
Extensive fibrosis 52 (3)
92 (7)
90 (1)
115 (2)
129 (3)
162 (2)
66 (4)
82 (3)
80 (5)
101 (2)
86 (2)
78 (4)
52 (2)
88 (1)
33 (1)
100 (6)
123 ±11
(6; P<0- 1)
76 ±10
(6; P<0 1)
102 (3)
36 ±13
(5; P<0-01)
36 (5)
48 (3)
13 (1)
42 (4)
35 (1)
30 (2)
189
84 (5)the de novo pathway of 5'-UMP synthesis-dihydroorotate dehydrogenase-is in
fact known to be present in parenchymal cells (Cohen, 1962). In some instances
there appeared to be up-and-down changes, for which Reid (1962a) has collated
other examples (e.g. Trams, Inscoe and Resnik, 1961) and suggested an explana-
tion-that cells other than a few destined to become cancerous mav " over-
compensate " for initial biochemical effects of the carcinogen treatment. Allow-
ing for such fluctuations, and for the variability sometimes encountered among
primary hepatomas but seldom explicable in terms of histological differences, the
findings suggest the following conclusions.
Relevance of the enzymic findings to azo-dye carcinogenesis.-The findings for
the metabolism of conjugated uridine nucleotides will first be considered. The
rise in UDPglucuronate transglucuronylase at about 3 weeks-as also found with
DAB feeding (Trams et al., 1961)-is evidently a non-specific response to the feed-
ing of azo dyes, metabolites of which are excreted as glucuronides; there is other
evidence (Takemori and Glowacki, 1962) that this enzyme is rate-limiting in
glucuronide synthesis. The fall in UDPglucose dehydrogenase seen during dye
feeding appeared, unlike the fall in UDPglucose pyrophosphorylase, to be speci-
fically correlated with carcinogenesis; but in rats fed DAB (Trams et al., 1961)
and in the present hepatomas the dehydrogenase activity was almost normal.
The fall in UDPglucose-glycogen transglucosylase in hepatomas may in part
explain their well-known lack ofglycogen (Reid, 1962a) ; but ifimpaired glycogen
storage is a very early event in hepatocarcinogenesis (Porter and Bruni, 1959;
Muramatsu, 1961), then the cause cannot be loss of this enzyme since it is uIn-
diminished in early-precancerous liver. These conclusions still hold if glycogen
synthesis is limited not by the enzyme but by the supply ofUDPglucose, data for
which are discussed below.
The observations on steps in the synthesis of UMP are summarized in Fig.
1. The activities of the different steps in the de novo pathway (from carbamyl-
aspartate) evidently do not change in parallel, although there is a general trend
towards an increase. The three enzyme systems concerned appear to show a
serial change, the first tending to be especially high with 5-20 days offeeding with
3'-Me-DAB and the third tending to be especially high with 21-41 days offeeding
as if there were stepwise " induction " of the different enzymes. However, the
results with 4'-F-DAB (Table I) were less clearcut. Moreover, from hormonal
and other data Reid (1962b) argued that the overall activity ofthe de novopathway
is governed by the " free " activity of the intermediate enzyme system which
converts carbamylaspartate into orotate. By this argument, the increase in this
activity found in rats fed 3'-Me-DAB and in the hepatomas connotes faster
operation of the whole pathway.
This conclusion may still hold if emphasis is put rather on the results for
carbamylaspartate formation, a process for which a supply of carbamylphosphate
is required. By virtue of the marked fall in the capacity for formation of orni-
thine (and ultimately of urea) from carbamylphosphate in azo-dye carcinogenesis
(McLean, Reid and Gurney, 1964; cf. Burke and Miller, 1959), channelling of
carbamylphosphate into the carbamylaspartate branch would be favoured,
provided that the fall in aspartate in azo-dye carcinogenesis (Muramatsu, 1961)
is not so great as to render aspartate rate-limiting (cf. Smith and Baker, 1959).
There may, then, be acceleration ofthe de novo pathway, and also ofthe salvage
pathway as judged by the uridine kinase assays (Fig. 1). At 5 days ofdye feeding
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uridine kinase already showed a rise in activity. Evidently the rise is not
secondary to a " deletion " in the de novo pathway. The histological results rule
out the possibility-suggested by the high uridine-kinase activity of rat bone
marrow (Sk6ld, 1960)-that leucocyte infiltration might account for the high
values in precancerous liver or hepatomas.
With regard to the catabolism of uridine nucleotides, increased " free"
activity ofthe enzyme(s) which dephosphorylate UTP is found both in hepatomas
and in liver from rats fed carcinogenic azo dyes for 3-6 weeks. The other cata-
bolic reactions studied showed no early changes specifically linked with carcino-
genic azo dyes, and no consistent decreases in the hepatomas.
Carbamyt -p Carbamyl - - Orot- 51-UMP Uridine
pophte 0.5)aiprtt ~ ate(07) b.a
Ttal"I Free
(O o55) (0002)
P.cooa025 P-c°° t1740
Pico-Os P<.cO0O5
C.- P<o-os P<0o05
0 -----
- -- -----
C
A
*40- Key:Ib-4at P.cooi R~~~~~~~~ER0U~~~S,-20
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P.C.0-Go;- * ,t'-41 DAYS
FIG. 1.-Activities (per g. of tissue) of enzymes concerned with synthesis of 5'-UMP, in pre-
cancerous liver (3'-Me-DAB) and in hepatoma nodules induced by 3'-Me-DAB. Figures in
parentheses represent the mean normal activity, in lumoles/g./min.
Re-examination of the enzymic findings in relation to changes in acid-soluble
nucleotide and RNA levels.-Fig. 2 shows, together with the present findings,
related findings such as the changes found by Nodes and Reid (1963) in the levels
ofacid-soluble nucleotides and in the activities of the enzymes which break RNA
down to 2'- or 3'-mononucleotides. Of the acid-soluble nucleotides, only the
uracil derivativeswill now beconsidered, sinceNodesandReid (1963) have already
discussed the findings forpurine nucleotides and for " pyridine " nucleotides such
as NAD.
The results for UDPglucose illustrate the difficulty of deciding whether a
change in the amount of a tissue constituent is due to altered synthesis or altered
utilization, and whether the rate-limiting factor for a particular reaction is the
enzyme level or the supply of a substrate. The level of UDPglucose rises in
precancerous liver and falls in hepatomas (Fig. 2). In hepatomas the fall may
be due in part to the diminished activity ofthe enzyme which effects the synthesis
191of UDPglucose from UTP and glucose-l-phosphate (the level of the latter being
undiminished in azo-dye hepatomas, Lepage, 1948); but the cause may lie mainly
in accelerated formation of mucopolysaccharide as discussed by Nodes and Reid
(1963), by reactions involving UDPglucuronate derived from UDPglucose. In
the case of precancerous liver, the rises in ULDPglucose and in UDPglucuronate
can be attributed to faster production, reflecting increased availability of 5'-UMP
and meeting an increased need in connection not with building fibrous tissue as in
hepatomas, but perhaps with synthesis of ascorbic acid (cf. Daff, Hoch-Ligeti,
4 R4 A 2M-AMP AMP Z-AP---"-AdmsWims 9* W4
miL. 4XKthEmh,
ris.c.t,sL. ric acid
ovi ~ ~~,gv. - W
P _-5 P-Ump 0 3-UEM Uridi cU oDihydr
RNA and ntot precan-
GDP ATP- NAD--N4ADPUD
~~~~~~~~~ ~~~~~~~~KEY
ADP NO~~UP~UP~mcs
UDPqkcromut..
GlscuoMdss4a ,Ic~
FiG. 2.-Levels of RNA and of acid-soluble nucleotides, and activites of enzymes concerned in
RNA and nucleotide metabolism :-summary of findings in this laboratory for precan-
cerous liver (3'-Me-DAB, fed for 2-5 weeks) and for primary hepatoma nodules.
Changes (per g. tissue) in the levelofRNA in a cell fraction, or ofan acid-soluble nucleotide
measured in whole liver, are shown above the entry for the constituent; changes (per g.
tissue) in the activity of an enzyme in vitro are shown below the arrow for the reaction.
The ribonucleases and phosphodiesterases concerned in RNA breakdown were assayed in
individual sub-cellularfractions (NodesandReid, 1963). ForATP-ase (ReidandO'Neal, 1956)
and for other enzymes which are partly " latent ", the change shown is for the " total "
activity. The findings for adenosine catabolism, for nuclear RNA, and for RNA in other
fractions are those of Reid and Lewin (1957), of M. K. Turner (unpublished experiments)
and of Reid (1958) respectively.
Kennaway and Tipler, 1948, and Conney, Bray, Evans and Burns, 1961) and
particularly of glucuronides.*
The general rise in uridine nucleotide levels in precancerous liver is attributable
to faster UMP synthesis by the de novo and salvage pathways (Fig. 1 and 2),
from the enzymic evidence discussed above. It is unlikely that the depletion in
ATP level (Fig. 2) renders ATP a limiting factor in UMP synthesis. The supply
of uridine for the salvage pathway may actually be enhanced, since RNA break-
down appears to be accelerated and uracil catabolism depressed (Fig. 2). The
conclusion that UMP synthesis is accelerated is supported by the finding that,
in rats fed 3'-Me-DAB, UMP showed a greater rise in level than other uridine
* Note added in proof:
At the suggestion of Dr. J. E. Scott, nodules rich in fibrous tissue have now been treated with
different stains (byMr. E. Woollard), andcollagen was found to predominate over mucopolysaccharide.
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nucleotides (Nodes and Reid, 1963). This preferential rise could, however, be
due in part to slower catabolism of UMP, there being a fall in 5'-nucleotidase
activity, and in part to impaired conversion of UMP to UDP and thence to UTP
because of the fall in ATP level. One factor which would set a limit to the rise
is feed-back inhibition, by UMP itself (Blair and Potter, 1961 ; Creasey and
Handschumacher, 1961), of orotidylate decarboxylase, the last enzyme in the
de novo pathway.
In the hepatomas (Fig. 2), despite the enzymic evidence for faster synthesis
ofUMP there was no consistent increases in the level ofUMP or ofUTP, although
there was an increase in UDP level due probably to faster dephosphorylation of
UTP. If in the hepatomas there is indeed faster synthesis ofuridine nucleotides,
this may be outweighed by the postulated faster consumption of UDPacetyl-
glucosamine and UDPglucuronate, and by faster incorporation ofUTP into RNA
(Reid, 1958, and unpublished experiments).
That there may be faster breakdown ofRNA to nucleotides, both in precance-
rous liver and in the hepatomas, is suggested by the observation of Nodes and
Reid (1963) that the acid-ribonuclease activity of the supernatant fraction (as
distinct from the activity bound in lysosomes) is increased, even before micro-
somal RNA decreases (Reid, 1964). Breakdown of the nucleotide products to
give inosine or uracil (Fig. 2) is evidently undiminished, if not accelerated, even
in hepatomas. The classical view that catabolic reactions are suppressed in
tumours may nevertheless have some validity for late steps in nucleotide cata-
bolism, since low activity has been observed for xanthine oxidase and, with some
but not all of the hepatomas studied, for uracil reductase. The fall in NADPH2
in the hepatomas may, however, restrict uracil reduction in vivso (Fritzon, 1960).
Are any of the findingsgenerally applicable to hepatocarcinogenesis?-Dihydro-
uracil dehydrogenase, which is non-specifically depressed by azo-dye feeding, is
likewise depressed by 2-acetylaminofluorene (P. Fritzon, personal communica-
tion). This carcinogen also resembles the azo-dyes now studied in causing a
transient rise in glucuronyl transferase and fall in UDPglucose dehydrogenase
(Trams et al., 1961). Otherwise there appears to be no information concerning
early effects of hepatocarcinogens other than azo dyes on the enzymic activities
now studied. Information concerning these activities in primary hepatomas
is also lacking, except for the report of Calva et al. (1959) who found increased
aspartate transcarbamylase in azo-dye hepatomas as in the present study.
Accordingly, for the purpose of deciding whether the changes now found in
primary hepatomas are irreducible properties of hepatomas, comparison must be
made with transplanted hepatomas. The Novikoff hepatoma shows low activity
for UDPglucose pyrophosphorylase, for the glycogen-synthesizing enzyme and-
in contrast with the hepatomas now studied-for UDPglucose dehydrogenase
(Nigam, MacDonald and Cantero, 1962). However, comparison with the Novikoff
hepatoma (for which Novikoff (1960) has summarized the literature) is unpro-
fitable, since there is now ample evidence (e.g. Potter et al., 1960; Ono et al., 1963)
that this hepatoma is highly uncharacteristic. Comparison can, however,
advantageously be made with "minimum deviation " heptomas such as the Morris
5123.
Morris 5123 hepatomas, unlike those now studied, show no elevation of as-
partate transcarbamylase activity (Ono et al., 1963), a normal capacity for con-
version of carbamylaspartate into orotate (Reid and Morris, 1963), and only a
193moderate impairment of the capacity for converting orotate into UMP (Ono et
al., 1963; Reid and Morris, 1963). Moreover, uridine kinase activity in Morris
5123 hepatomas is normal (Reid and Morris, 1963). There is, then, no evidence
for accelerated formation of UMP in the Morris 5123 hepatoma; the apparent
acceleration in the azo-dye hepatomas now studied may, in accordance with a
suggestion by Sk6ld (1960), be a reflection of the great rapidity of their growth.
It is striking that abnormally high activities have been found for uridine kinase
in human tumours (Kara, Sorm and Winkler, 1963) and for enzymes of the de
novo pathway for UMP synthesis in leukaemic leucocytes (Smith, Baker and
Sullivan, 1960). Moreover, there is evidence that the latter pathway is affected
-whether blocked or stimulated is not clear-in urethane carcinogenesis (Rogers,
1957). Although faster UMP synthesis is not an absolute requisite for neoplastic
growth, it may be apre-requisite, since it was in evidence not only in the primary
hepatomas but also in " hyperplastic nodules " and in precancerous liver.
One of the catabolic steps now found to be altered-the " free " capacity for
dephosphorylation of UTP-may also be high in the Morris 5123 hepatoma;
but UDPglucose pyrophosphorylase activity was normal in the 5123 hepatoma
(Reid and Morris, 1963). In two respects, however, the primary hepatomas
may have been more " mimimum-deviation " in type than 5123 hepatomas: the
latter tend to be low in UDPglucose dehydrogenase (Reid and Morris, 1963)
and especially in glucuronide-synthesizing activity (Novikoff, 1960), whereas these
enzymes were normal in many of the hepatomas now studied.
In general the present enzymic comparisons of primary hepatomas with
normal liver have shown relatively few differences (" deviations "), but the
hepatomas were evidently not of the " minimum-deviation " type in respect of
all these differences. One important conclusion is that, contrary to a belief
based, for example, on uracil catabolism in a mouse hepatoma (Canellakis, 1957),
catabolic reactions may be undiminished in tumours.
The results presented and discussed in the preceding papers (Nodes and Reid,
1963; Reid, 1964) do suggest some provisional generalizations about hepatoma
cells, irrespective of whether the cells appear " necrotic ". In whole tissue there
are markedly lowered levels of UDPglucuronate, NADPH2 (and usually NADP),
and certain purine nucleotides other than ATP. The acid-soluble purine nucleo-
tides of isolated mitochondria are depleted, as are mitochondrial protein and
microsomal protein and RNA. The turnover of RNA is faster, there being accele-
ration both of its synthesis as judged by orotate incorporation in vivo and of its
catabolism as judged by the acid-ribonuclease activity ofthe supernatant fraction.
Most of the changes found in primary hepatomas are already evident at some
stage early in the feeding period.
SUMMARY
Enzymes concerned in the metabolism ofuridine nucleotides have been assayed
in primary hepatomas, and in liver from rats fed carcinogenic or non-carcinogenic
azo dyes. The histological character ofthe hepatomas, e.g. the degree ofnecrosis,
had no clear influence on the results.
Precancerous liver showed, in the de novo pathway for synthesis of 5'-UMP, an
eventual slight decrease in " step 1 " (carbamylaspartate formation), and moderate
increases in " step 2 " (orotate formation) and " step 3 " (UMP formation) ; the
overall capacity for UMP synthesis is considered to be slightly increased. In the
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hepatomas steps 1 and 2 showed increased activity, and although step 3 showed
decreased activity it is considered that the capacity for de novo synthesis of UMIP
was increased. As judged by the assays for uridine kinase, the salvage pathway
for synthesis of UMP was likewise increased in azo-dye hepatomas, and in rats fed
carcinogenic azo dyes.
Assays on precancerous liver for enzymes concerned in nucleotide catabolism
showed an eventual rise in the " free " capacity for UTP dephosphorylation, and
a decrease-apparently not specifically related to carcinogenesis-in dihydrouracil
dehydrogenase. In the hepatomas the former activity was high and the latter
was usually close to normal. None of the catabolic enzymes measured showed
consistently low activity in the hepatomas.
UDPglucose pyrophosphorylase was somewhat low in the hepatomas, but
in precancerous liver there was no change specifically related to carcinogenesis.
UDPglucose dehydrogenase showed little change in hepatomas but a specific
depression in precancerous liver. Glucuronide-synthesizing activity showed a
non-specific rise in precancerous liver. Glycogen-synthesizing activity was low
in the hepatomas.
The results are discussed in relation to their bearing on data for nucleotide
levels (Nodes and Reid, 1963), and to their significance for hepatocarcinogenesis.
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